Cintia Piccina

Insider Reports History

Location
60 Jubilee Avenue, Milton Park, Abingdon, Oxfordshire, United Kingdom
Signature
/s/ Cintia Piccina
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Cintia Piccina:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Allovir, Inc. Chief Commercial Officer Common Stock 147K $98.6K $0.67 Jul 3, 2023 Direct
Adaptimmune Therapeutics PLC Chief Commercial Officer American Depositary Shares representing Ordinary Shares 18.4K $10.6K $0.57 Jan 15, 2025 Direct
Adaptimmune Therapeutics PLC Chief Commercial Officer Option to purchase Ordinary Shares 1.07M Feb 20, 2025 Direct
Allovir, Inc. Chief Commercial Officer Stock Option (Right to Buy) 273K Jul 3, 2023 Direct

Insider Reports Filed by Cintia Piccina

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ADAP Adaptimmune Therapeutics PLC Feb 20, 2025 2 $0 4 Feb 20, 2025 Chief Commercial Officer
ADAP Adaptimmune Therapeutics PLC Jan 15, 2025 1 -$7.47K 4 Jan 15, 2025 Chief Commercial Officer
ADAP Adaptimmune Therapeutics PLC Jun 18, 2024 1 -$22.8K 4 Jun 18, 2024 Chief Commercial Officer
ADAP Adaptimmune Therapeutics PLC Mar 18, 2024 2 $0 4 Mar 18, 2024 Chief Commercial Officer
ALVR Allovir, Inc. Jul 3, 2023 2 $0 4 Jul 5, 2023 Chief Commercial Officer
ALVR Allovir, Inc. Jun 12, 2023 0 $0 3 Jun 21, 2023 Chief Commercial Officer
ADAP Adaptimmune Therapeutics PLC Jan 31, 2023 1 -$22.2K 4 Jan 31, 2023 Chief Commercial Officer
ADAP Adaptimmune Therapeutics PLC Jan 17, 2023 3 $0 4 Jan 17, 2023 Chief Commercial Officer
ADAP Adaptimmune Therapeutics PLC Aug 1, 2022 1 -$37.3K 4 Aug 1, 2022 Chief Commercial Officer
ADAP Adaptimmune Therapeutics PLC Jan 31, 2022 3 $0 4 Jan 31, 2022 Chief Commercial Officer
ADAP Adaptimmune Therapeutics PLC Jan 31, 2022 0 $0 3 Jan 31, 2022 Chief Commercial Officer